Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure

Author: Freudenberger Ronald S   Schwarz Jr Richard P   Brown Joanne   Moore Alan   Mann Douglas   Givertz Michael M   Colucci Wilson S   Hare Joshua M  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.13, Iss.11, 2004-11, pp. : 1509-1516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content